Back to top

Quince Therapeutics initiated with an Outperform at Citizens JMP

Citizens JMP initiated coverage of Quince Therapeutics (QNCX) with an Outperform rating and $9 price target The firm says Quince is using its Autol...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Quince Therapeutics, Inc. (QNCX)